In the Type 2 Diabetes Group, there was a sample size of 710 patients (194 on GLP-1, 516 on non-GLP-1 RA medications) with a NAION incidence of 17 events in the GLP-1 group vs
The composite endpoint, time to 3P MACE, was significant for noninferiority (HR 0.98, 95% CI 0.841.14
By bypassing the gastrointestinal tract and first-pass hepatic metabolism, the system supports lower peak-to-trough fluctuations in serum estrogen concentration than oral formulations while maintaining clinically relevant exposure equivalent to endogenous levels observed during the early-to-mid follicular phase of the menstrual cycle
This dual mechanism is why tirzepatide produces greater weight loss in clinical trials and why the dosing numbers look completely different
Reheat in a covered skillet, not the microwave
Clinical Efficacy Substantial Weight Reduction: Clinical trials and real-world evidence have shown that Ozempic can lead to significant weight loss, particularly when combined with lifestyle modifications such as diet and exercise